Back to Search
WILLIAM STEWART, MD
MD
Plastic Surgery Physician
NPI: 1447257035IndividualAccepts Medicare
Specialties, Licenses & Credentials
Plastic Surgery PhysicianPrimary
Plastic Surgery
Code: 208200000X
15926(WV)
CMS Specialties
Education
WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE
Class of 1988
Clinical Trials (5)
5
Linked Trials
0
Recruiting
1
With Results
Patient Satisfaction With Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension
NCT00804648COMPLETEDPHASE4STUDY_DIRECTOR
Assessing Cosopt Switch Patients
NCT00273442COMPLETEDPHASE4STUDY_DIRECTOR
Lumigan Versus Cosopt
NCT00273455COMPLETEDPHASE4STUDY_DIRECTOR
Cosopt Versus Xalatan
NCT00273429COMPLETEDPHASE4STUDY_DIRECTOR
Soothe Versus Refresh
NCT00284999COMPLETEDPHASE4STUDY_DIRECTOR
Research & Publications (20)
Cost-effectiveness of latanoprost and timolol maleate for the treatment of glaucoma in Scandinavia and the United Kingdom, using a decision-analytic health economic model.
PMID 17721497·Eye (Lond)·2009
4-observational
Ocular blood flow in glaucoma: the need for further clinical evidence and patient outcomes research.
PMID 17895414·Br J Ophthalmol·2007
6-review
Mean intraocular pressure and progression based on corneal thickness in primary open-angle glaucoma.
PMID 16503772·J Ocul Pharmacol Ther·2006
8-other
Patient and ophthalmologist attitudes concerning compliance and dosing in glaucoma treatment.
PMID 15684806·J Ocul Pharmacol Ther·2004
4-observational
The safety and efficacy of unoprostone 0.15% versus brimonidine 0.2%.
PMID 15043534·Acta Ophthalmol Scand·2004
3-trial
Efficacy and safety of the latanoprost/timolol maleate fixed combination vs concomitant brimonidine and latanoprost therapy.
PMID 15037890·Eye (Lond)·2004
3-trial
Short-term ocular tolerability of dorzolamide 2% and brinzolamide 1% vs placebo in primary open-angle glaucoma and ocular hypertension subjects.
PMID 15002017·Eye (Lond)·2004
3-trial
Conjunctival hyperemia in healthy subjects after short-term dosing with latanoprost, bimatoprost, and travoprost.
PMID 12614748·Am J Ophthalmol·2003
3-trial
Corneal punctate staining with latanoprost, bimatoprost, and travoprost in healthy subjects.
PMID 14646682·J Glaucoma·2003
3-trial
Prevention of corticosteroid-induced intraocular pressure elevation using ISV-205.
PMID 14609909·Arch Ophthalmol·2003
3-trial
Efficacy and safety of timolol maleate/latanoprost fixed combination versus timolol maleate and brimonidine given twice daily.
PMID 12780402·Acta Ophthalmol Scand·2003
3-trial
Acute and chronic ocular symptoms of dorzolamide 2% compared with placebo.
PMID 12671470·J Glaucoma·2003
3-trial
The safety and efficacy of timolol 0.5% in xanthan gum versus timolol gel forming solution 0.5%.
PMID 12434307·Curr Eye Res·2002
3-trial
Tolerability and efficacy of dorzolamide versus acetazolamide added to timolol.
PMID 12099542·J Ocul Pharmacol Ther·2002
3-trial
Cardiovascular effects of timolol maleate, brimonidine or brimonidine/timolol maleate in concomitant therapy.
PMID 12059866·Acta Ophthalmol Scand·2002
3-trial
Comparison of the cardiovascular effects of unoprostone 0.15%, timolol 0.5% and placebo in healthy adults during exercise using a treadmill test.
PMID 12059865·Acta Ophthalmol Scand·2002
3-trial
Effect of timolol 0.5% gel and solution on pulmonary function in older glaucoma patients.
PMID 11442188·J Glaucoma·2001
3-trial
Washout periods for brimonidine 0.2% and latanoprost 0.005%.
PMID 11384581·Am J Ophthalmol·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 210 BROOKS ST STE 200
CHARLESTON, WV 25301 - Phone
- (304) 388-1930
Quick Facts
- NPI
- 1447257035
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 38
- Clinical Trials
- 5
- Publications
- 20
Are you this provider?
Claim Your Profile